The Watch the Spot Trial

NACompletedINTERVENTIONAL
Enrollment

34,686

Participants

Timeline

Start Date

March 6, 2017

Primary Completion Date

September 4, 2024

Study Completion Date

September 4, 2024

Conditions
Solitary Pulmonary NoduleCoin Lesion, PulmonaryLung NeoplasmsCarcinoma, Non-small-cell Lung
Interventions
OTHER

More Frequent Surveillance Strategy

Chest CT scans to be repeated at 3, 6, 12 and/or 24 months, depending on patient risk factors and nodule size and attenuation (density)

OTHER

Less Frequent Surveillance Strategy

Chest CT scans to be repeated at 3, 6, 12 and/or 24 months, depending on patient risk factors and nodule size and attenuation (density). Overall, participants in the less frequent arm are expected to undergo 30% fewer surveillance imaging tests.

Trial Locations (1)

91011

Kaiser Permanente Southern California, Pasadena

All Listed Sponsors
collaborator

Patient-Centered Outcomes Research Institute

OTHER

collaborator

University of California, Davis

OTHER

collaborator

University of California, San Francisco

OTHER

lead

Kaiser Permanente

OTHER

NCT02623712 - The Watch the Spot Trial | Biotech Hunter | Biotech Hunter